SCHEMBL6173502

SCHEMBL6173502

CC(c1ccnc(N2CCOCC2)c1)C1(C(C)c2ccnc(N3CCOCC3)c2)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 15/20 0.38
ABL1 P00519 2/20 0.35
LRRK2 Q5S007 1/20 0.35
ITGB2 P05107 1/20 0.34
ICAM1 P05362 1/20 0.34
ITGAL P20701 1/20 0.34
PIK3CA P42336 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6176024 0.91 IGF1R (0.41) IGF1RITGB2ICAM1ITGAL
SCHEMBL6173512 0.90 ADRB1 (0.40) IGF1R
SCHEMBL6172644 0.90 IGF1R (0.40) IGF1R
SCHEMBL6174968 0.89 ITGB2 (0.39) IGF1RITGB2ICAM1ITGAL
SCHEMBL6174466 0.86 SYK (0.40) IGF1RABL1
SCHEMBL6172577 0.86 ABL1 (0.46) ABL1LRRK2PIK3CA
SCHEMBL6173405 0.85 IGF1R (0.40) IGF1R
SCHEMBL17558382 0.84 IGF1R (0.39) IGF1R
SCHEMBL6172820 0.82 IGF1R (0.42) IGF1R
SCHEMBL6174494 0.82 IGF1R (0.42) IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3188729-A1 CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS Genzyme Corporation (US) 2017-07-12 EP disclosed
WO-2016036796-A1 CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS GENZYME CORPORATION (US) 2016-03-10 WO disclosed
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed